CD8A and neoplasm: Cyclophosphamide chemotherapy could sensitize tumor cells to the tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAILR) dependent CD8+ T cell-mediated immune attack, resulting in the suppression of tumor growth (27).